MedTrace Logo

Molecular Diagnosis of Systemic Autoinflammatory Diseases

NCT05364294 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-03-05

No results posted yet for this study

Summary

Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.

Conditions

  • Inflammatory Disease
  • Genetic Disease
  • Somatic Mutation
  • Molecular Sequence Variation
  • Molecular Pathway Deregulation

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Eligibility

Min Age
1 Week
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-18
Primary Completion
2032-05-31
Completion
2033-05-02

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05364294 on ClinicalTrials.gov